会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SUSTAINED RELEASE PREPARATIONS
    • 持续发布准备
    • WO2005117843A2
    • 2005-12-15
    • PCT/US2005/016528
    • 2005-05-11
    • MALLINCKRODT INC.RAMAN, Siva, N.CUNNINGHAM, John, P.LANG, John, F.
    • RAMAN, Siva, N.CUNNINGHAM, John, P.LANG, John, F.
    • A61K9/50
    • A61K31/785A61K9/0095A61K9/5036A61K47/585
    • Disclosed are sustained release drug particles suitable for forming sustained release oral pharmaceutical compositions. The sustained release drug particles comprise a drug-ion exchange resin complex and a water-permeable, diffusion barrier surrounding at least a portion of the drug-ion exchange resin complex. The diffusion barrier comprises a film-forming polymer and is free or contains no substantial traces of organic solvent. Also disclosed are oral pharmaceutical compositions, for example, oral suspensions, comprising the sustained release drug particles, a method for the controlled administration of a drug to a patient, and a method for manufacturing the sustained release drug particles. The method of manufacturing involves the use of an aqueous coating composition comprising a water-permeable film-forming polymer such as ethylcellulose.
    • 公开了适于形成缓释口服药物组合物的缓释药物颗粒。 缓释药物颗粒包含药物 - 离子交换树脂复合物和围绕药物 - 离子交换树脂复合物的至少一部分的透水的扩散阻挡层。 扩散阻挡层包含成膜聚合物,并且不含或不含有实质痕量的有机溶剂。 还公开了口服药物组合物,例如包含缓释药物颗粒的口服悬浮液,用于向患者控制施用药物的方法和制备缓释药物颗粒的方法。 制造方法涉及使用包含透水性成膜聚合物如乙基纤维素的水性涂料组合物。